Pitolisant

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 236 publications

Psychopharmacology of Eugeroics-The Whole Nine Yards!

Psychopharmacology of Eugeroics-The Whole Nine Yards!

Journal: Psychopharmacology bulletin

Published: June 10, 2026

Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.

Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.

Journal: Molecular diversity

Published: March 29, 2026

Histamine shapes the neurocomputational dynamics of human learning.

Histamine shapes the neurocomputational dynamics of human learning.

Journal: Nature communications

Published: March 17, 2026

Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia

Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: March 01, 2026

Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation.

Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation.

Journal: Expert opinion on investigational drugs

Published: February 23, 2026

Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors.

Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors.

Journal: International journal of molecular sciences

Published: December 05, 2025

Pitolisant-associated mania - a case report.

Pitolisant-associated mania - a case report.

Journal: BMC neurology

Published: December 01, 2025

Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: The Annals of pharmacotherapy

Published: December 01, 2025

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Journal: Drugs

Published: November 26, 2025

Reciprocal regulation of the H3 histamine receptor in Rett syndrome and MECP2 Duplication syndrome: implications for therapeutic development.

Reciprocal regulation of the H3 histamine receptor in Rett syndrome and MECP2 Duplication syndrome: implications for therapeutic development.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

A real-world study on the treatment of pediatric narcolepsy with pitolisant in China.

A real-world study on the treatment of pediatric narcolepsy with pitolisant in China.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 03, 2025

Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship.

Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship.

Journal: The open respiratory medicine journal

Published: October 26, 2025

Showing 1-12 of 236

Last Updated: 06/30/2026